Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1995-5-22
pubmed:abstractText
The authors previously conducted a pilot, dose-escalating study which suggested that a 20-micrograms dose of intravitreal cidofovir (HPMPC) may be safe and effective in treating cytomegalovirus (CMV) retinitis in humans. The purpose of this series is to expand the authors' prior experience with the 20-micrograms dose of cidofovir as the sole treatment for CMV retinitis in patients with acquired immune deficiency syndrome.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0161-6420
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
533-42; discussion 542-3
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7724170-AIDS-Related Opportunistic Infections, pubmed-meshheading:7724170-Acquired Immunodeficiency Syndrome, pubmed-meshheading:7724170-Adult, pubmed-meshheading:7724170-Antiviral Agents, pubmed-meshheading:7724170-Ciliary Body, pubmed-meshheading:7724170-Cytomegalovirus Retinitis, pubmed-meshheading:7724170-Cytosine, pubmed-meshheading:7724170-Drug Therapy, Combination, pubmed-meshheading:7724170-Female, pubmed-meshheading:7724170-Humans, pubmed-meshheading:7724170-Injections, pubmed-meshheading:7724170-Intraocular Pressure, pubmed-meshheading:7724170-Male, pubmed-meshheading:7724170-Middle Aged, pubmed-meshheading:7724170-Organophosphorus Compounds, pubmed-meshheading:7724170-Phosphonic Acids, pubmed-meshheading:7724170-Probenecid, pubmed-meshheading:7724170-Retina, pubmed-meshheading:7724170-Uveitis, pubmed-meshheading:7724170-Vitreous Body
pubmed:year
1995
pubmed:articleTitle
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
pubmed:affiliation
Department of Ophthalmology, Shiley Eye Center, University of California at San Diego, La Jolla 92093-0946, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't